PROCTER & GAMBLE HEALTH
Back to Cashflow Statement
|
PROCTER & GAMBLE HEALTH Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Jun2024 | Jun2023 | Jun2022 | Jun2021 | Jun2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-418 Cr | ₹-98 Cr | ₹-289 Cr | ₹-387 Cr | ₹-883 Cr |
What is the latest Cash Flow from Financing Activities ratio of PROCTER & GAMBLE HEALTH ?
Year | Cash Flow from Financing Activities |
---|---|
Jun2024 | ₹-418 Cr |
Jun2023 | ₹-98 Cr |
Jun2022 | ₹-289 Cr |
Jun2021 | ₹-387 Cr |
Jun2020 | ₹-883 Cr |
How is Cash Flow from Financing Activities of PROCTER & GAMBLE HEALTH Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Jun2024 | ₹-418 Cr | Negative | |
Jun2023 | ₹-98 Cr | Negative | |
Jun2022 | ₹-289 Cr | Negative | |
Jun2021 | ₹-387 Cr | Negative | |
Jun2020 | ₹-883 Cr | - |
Compare Cash Flow from Financing Activities of peers of PROCTER & GAMBLE HEALTH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PROCTER & GAMBLE HEALTH | ₹10,268.0 Cr | 4% | 7.1% | 18.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,607.0 Cr | -5.9% | -2.8% | -5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹170,148.0 Cr | -3.7% | -6.9% | 30.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,471.0 Cr | -3.8% | 7.1% | 12% | Stock Analytics | |
CIPLA | ₹121,103.0 Cr | -3.9% | -0.8% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,306.0 Cr | -6% | -7.3% | -12% | Stock Analytics |
PROCTER & GAMBLE HEALTH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PROCTER & GAMBLE HEALTH | 4% |
7.1% |
18.7% |
SENSEX | -0.8% |
-3.3% |
-1.4% |
You may also like the below Video Courses